Skip to content

Ablation of Supraventricular Arrhythmias With As Low As Reasonably Achievable X-Ray Exposure

Ablation of Supraventricular Arrhythmias With As Low As Reasonably Achievable X-Ray Exposure (AALARA)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04716270
Acronym
AALARA
Enrollment
700
Registered
2021-01-20
Start date
2021-01-20
Completion date
2023-03-31
Last updated
2022-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tachycardia, Supraventricular

Keywords

Supraventricular tachycardia, Radiation exposure

Brief summary

Observational study is to demonstrate a clinically significant reduction of ionizing radiation exposure during transcatheter ablation of supraventricular tachycardias using the EnSite precision mapping system in a real-world clinical setting without compromising efficacy and safety.

Interventions

PROCEDUREElectrophysiology Study and Ablation

Electrophysiology Study and Ablation of Supraventricular Arrhythmias

Sponsors

Mohamed Bin Khalifa Bin Sulman Al Khalifa Cardiac Centre
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female patients ≥ 18 years of age * Patient indicated for supraventricular arrhythmias ablation according to the current guidelines * Patient is willing to provide written informed consent.

Exclusion criteria

* Patient is pregnant. * Contraindications to ionizing radiation exposure * Patient's life expectancy is less than 1 year * Associated complex congenital heart disease * Cardiac implantable electric devices * Known pathological venous access to the heart

Design outcomes

Primary

MeasureTime frameDescription
Radiation exposure doseThe day of performing the procedureThe dose of ionizing radiation exposure in patients undergoing Supraventricular Tachycardia catheter ablation utilizing a non-fluoroscopic EnSite Precision 3D mapping system
Incidence of procedure related cardiac Adverse Events (Safety)6 monthsCardiac related serious adverse events frequency during and after ablation procedure of supraventricular arrhythmias

Secondary

MeasureTime frameDescription
Fluoroscopy timeThe day of performing the procedureFluoroscopy time during the procedure

Countries

Bahrain

Contacts

Primary ContactMOHAMMAD AMIN
drmohdamin@gmail.com0097317767739

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026